Comparison of neutropenia in a randomized, crossover trial of 3-, 6-, and 24-h infusions of paclitaxel

Author： Jennens R.   Rischin D.   Yuen K.   Toner G.   Millward M.  

Publisher： Elsevier

ISSN： 0090-8258

Source： Gynecologic Oncology, Vol.91, Iss.1, 2003-10, pp. : 190-193

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Phase I Trial of Ifosfamide and 24-h Infusional Paclitaxel in Pelvic Malignancies: A Gynecologic Oncology Group Study

By Markman M.   Spriggs D.   Burger R.A.   Carson L.F.   Lentz S.S.   Gallion H.  

Gynecologic Oncology, Vol. 80, Iss. 3, 2001-03 ,pp. : 359-363

Elsevier

Access to resources Recommend Favorite

A double-blind, crossover, randomized dose-comparison trial of granisetron for the prevention of acute and delayed nausea and emesis in children receiving moderately emetogenic carboplatin-based chemotherapy

By Berrak Su  

Supportive Care in Cancer, Vol. 15, Iss. 10, 2007-10 ,pp. : 1163-1168

Springer Publishing Company

Access to resources Recommend Favorite

Chemoprophylaxis with Ciprofloxacin in Ovarian Cancer Patients Receiving Paclitaxel: A Randomized Trial

By Carlson J.W.   Fowler J.M.   Mitchell S.K.   Carson L.F.   Mayer A.R.   Copeland L.J.  

Gynecologic Oncology, Vol. 65, Iss. 2, 1997-05 ,pp. : 325-329

Elsevier

Access to resources Recommend Favorite

Individually tailored treatment with epirubicin and paclitaxel with or without capecitabine as first-line chemotherapy in metastatic breast cancer: a randomized multicenter trial

By Hatschek T.   Carlsson L.   Einbeigi Z.   Lidbrink E.   Linderholm B.   Lindh B.   Loman N.   Malmberg M.   Rotstein S.   Söderberg M.   Sundquist M.   Walz T.   Hellström M.   Svensson H.   Åström G.   Brandberg Y.   Carstensen J.   Fernö M.   Bergh J.  

Breast Cancer Research and Treatment, Vol. 131, Iss. 3, 2012-02 ,pp. : 939-947

Springer Publishing Company

Access to resources Recommend Favorite

A randomized phase-II trial comparing sequential and concurrent paclitaxel with oral or parenteral fluorinated pyrimidines for advanced or metastatic gastric cancer

By Nishikawa Kazuhiro   Morita Satoshi   Matsui Takanori   Kobayashi Michiya   Takeuchi Yoji   Takahashi Ikuo   Sato Seiji   Miyashita Yumi   Tsuburaya Akira   Sakamoto Junichi   Kakeji Yoshihiro   Baba Hideo  

Gastric Cancer, Vol. 15, Iss. 4, 2012-10 ,pp. : 363-369

Springer Publishing Company

Access to resources Recommend Favorite